Healthcare provider profile · identity verified

Vera Arnold, APRN, FNP

Nurse Practitioner · DAYTON, OH · NPI 1205384062

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	872	256
Amlodipine Besylate	Amlodipine Besylate	572	172
Albuterol Sulfate Hfa	Albuterol Sulfate	552	137
Losartan Potassium	Losartan Potassium	390	117
Hydrochlorothiazide	Hydrochlorothiazide	342	97
Lisinopril	Lisinopril	321	83
Metformin Hcl	Metformin Hcl	320	83
Gabapentin	Gabapentin	315	78
Omeprazole	Omeprazole	249	66
Metoprolol Succinate	Metoprolol Succinate	228	61
Furosemide	Furosemide	173	59
Levothyroxine Sodium	Levothyroxine Sodium	162	38
Hydroxyzine Hcl	Hydroxyzine Hcl	159	53
Famotidine	Famotidine	158	42
Fluticasone Propionate	Fluticasone Propionate	152	45
Hydralazine Hcl	Hydralazine Hcl	149	45
Ibuprofen	Ibuprofen	147	49
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	139	40
Pantoprazole Sodium	Pantoprazole Sodium	134	33
Duloxetine Hcl	Duloxetine Hcl	130	41
Potassium Chloride	Potassium Chloride	127	34
Metoprolol Tartrate	Metoprolol Tartrate	126	32
Rosuvastatin Calcium	Rosuvastatin Calcium	115	31
Methocarbamol	Methocarbamol	101	34
Tamsulosin Hcl	Tamsulosin Hcl	90	31
Allopurinol	Allopurinol	89	22
Carvedilol	Carvedilol	88	34
Farxiga	Dapagliflozin Propanediol	87	14
Montelukast Sodium	Montelukast Sodium	86	20
Clopidogrel	Clopidogrel Bisulfate	85	20
Donepezil Hcl	Donepezil Hcl	85	19
Eliquis	Apixaban	82	22
Trazodone Hcl	Trazodone Hcl	82	18
Simvastatin	Simvastatin	74	21
Meloxicam	Meloxicam	72	31
Jardiance	Empagliflozin	70	15
Glimepiride	Glimepiride	69	24
Spironolactone	Spironolactone	69	19
Amitriptyline Hcl	Amitriptyline Hcl	68	13
Ozempic	Semaglutide	67	14
Metformin Hcl Er	Metformin Hcl	62	15
Sertraline Hcl	Sertraline Hcl	55	14
Novolog Flexpen	Insulin Aspart	51	suppressed
Breo Ellipta	Fluticasone/Vilanterol	50	suppressed
Nifedipine Er	Nifedipine	50	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	16
Meclizine Hcl	Meclizine Hcl	49	15
Advair Hfa	Fluticasone Propion/Salmeterol	46	suppressed
Mirtazapine	Mirtazapine	46	11
Tramadol Hcl	Tramadol Hcl	44	15
Xarelto	Rivaroxaban	43	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Glipizide	Glipizide	40	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	14
Myrbetriq	Mirabegron	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	12
Bupropion Xl	Bupropion Hcl	35	suppressed
Prednisolone Sodium Phosphate	Prednisolone Sodium Phosphate	35	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	14
Triamcinolone Acetonide	Triamcinolone Acetonide	34	suppressed
Ventolin Hfa	Albuterol Sulfate	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	11
Torsemide	Torsemide	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Tresiba Flextouch U-200	Insulin Degludec	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Cephalexin	Cephalexin	20	14
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Nitroglycerin	Nitroglycerin	20	14
Sucralfate	Sucralfate	20	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Dulera	Mometasone/Formoterol	19	suppressed
Linzess	Linaclotide	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Nystatin	Nystatin	18	suppressed
Atenolol	Atenolol	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Prednisone	Prednisone	17	15
Hydrocortisone	Hydrocortisone	16	11
Propranolol Hcl	Propranolol Hcl	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Methimazole	Methimazole	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Naproxen	Naproxen	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Valsartan	Valsartan	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nyamyc	Nystatin	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error